WSR 15-04-108 PROPOSED RULES HORSE RACING COMMISSION [Filed February 3, 2015, 8:47 a.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 14-22-066.
Title of Rule and Other Identifying Information: WAC 260-70-630 Thresholds.
Hearing Location(s): Auburn City Council Chambers, 25 West Main, Auburn, WA 98002, on March 13, 2015, at 9:30 a.m.
Date of Intended Adoption: March 13, 2015.
Submit Written Comments to: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, e-mail doug.moore@whrc.state.wa.us, fax (360) 459-6461, by March 9, 2015.
Assistance for Persons with Disabilities: Contact Patty Sorby by March 9, 2015, TTY (360) 459-6462.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: Amends the threshold for the substance, xylazine.
Reasons Supporting Proposal: The original threshold for xylazine was not based on current, published research and does not allow for reasonable administration.
Statutory Authority for Adoption: RCW 67.16.020.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: [Horse racing commission], governmental.
Name of Agency Personnel Responsible for Drafting, Implementation, and Enforcement: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, (360) 459-6462.
No small business economic impact statement has been prepared under chapter 19.85 RCW. Not applicable.
A cost-benefit analysis is not required under RCW 34.05.328. Not applicable.
February 3, 2015
Douglas L. Moore
Executive Secretary
AMENDATORY SECTION (Amending WSR 14-13-074, filed 6/13/14, effective 7/14/14)
WAC 260-70-630 Threshold levels.
(1) Permitted medications.
(a) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in urine:
Acepromazine - 25 ng/ml
Albuterol - 1 ng/ml
Bupivicaine - 5 ng/ml
Detomidine - 1 ng/ml
Mepivacaine - 10 ng/ml
Omeprozole - 1 ng/ml
Promazine - 25 ng/ml
Pyrilamine - 25 ng/ml
(b) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in serum or plasma:
Betamethasone - 10 pg/ml
Butorphanol - 2 ng/ml
Clenbuterol - 25 pg/ml
Dantrolene - 100 pg/ml
Dexamethasone - 1 ng/ml
Diclofenac - 5 ng/ml
DMSO - 10 mc/ml
Firocoxib - 40 ng/ml
Glycopryrrolate - 3 pg/ml
Isoflupredone - 100 pg/ml
Lidocaine - 20 pg/ml
Methocarbamol - 1 ng/ml
Methylprednisolone - 1.3 ng/ml
Prednisolone - 1 ng/ml
*Procaine penicillin - 25 ng/ml
Triamcinolone - 100 pg/ml
Xylazine - ((0.01)) 0.5 ng/ml
(c) The official urine or blood test sample may not contain more than one of the above substances, including their metabolites or analogs, and may not exceed the concentrations established in this rule.
(2) Environmental substances.
(a) Certain substances can be considered "environmental" in that they are endogenous to the horse or that they can arise from plants traditionally grazed or harvested as equine feed or are present in equine feed because of contamination or exposure during the cultivation, processing, treatment, storage, or transportation phases. Certain drugs are recognized as substances of human use and could therefore be found in a horse. The following substances are permissible in test samples up to the stated concentrations:
Arsenic - 0.3 mc/ml urine
Caffeine - 100 ng/ml serum or plasma
Benzoylecgonine - 50 ng/ml urine
Estranediol - 0.045 mc/ml free + conjugated (5a-oestrane-3β,17a-diol), in male horses, other than geldings
Hydrocortisone - 1 mc/ml urine
Methoxytyramine - 4 mc/ml, free + conjugated urine
Morphine Glucuronides - 50 ng/ml urine
Salicylate saliclic acid - 750 mc/ml serum or plasma
Theobromine - 2 mc/ml urine
(b) If a preponderance of evidence presented shows that a positive test is the result of environmental substance or inadvertent exposure due to human drug use, that evidence should be considered as a mitigating factor in any disciplinary action taken against the trainer.
(3) Androgenic-anabolic steroids.
(a) The following androgenic-anabolic steroids are permissible in test samples up to the stated concentrations:
Boldenone (Equipoise) - 15 ng/ml urine in intact males. No level is permitted in geldings, fillies or mares.
Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fillies, and mares, and for nandrolone metabolite (5a-oestrane-3β,17a-diol) - 45 ng/ml urine in intact males.
Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine in fillies and mares. Samples from intact males will not be tested for the presence of testosterone.
(b) All other androgenic-anabolic steroids are prohibited in race horses.
| ||||